Michele C.
- Country
- Italy
- Department
- UOC Gastroenterologia
Research Overview
- A randomized, double-blind, multicenter phase III study to evaluate the long-term efficacy and safety of ABX464 25 mg or 50 mg once daily as a maintenance therapy in subjects with moderately to severely active ulcerative colitis
- Efficacy and Safety of Obefazimod (ABX464) in Adults with Moderately to Severely Active Ulcerative Colitis: A Randomized Placebo‑Controlled Phase III Study
- Phase 2 Multicenter Double-Blind Study of Subcutaneous PF-06480605 in Moderate to Severe Active Crohn's Disease
Data & Insights
Has run more than one trial at 244 of 423 partner sites.
Specializations
Inflammatory Bowel Disease Management
This investigator specializes in treating inflammatory bowel disease (IBD), with particular expertise in both Crohn's disease and ulcerative colitis. Their research focuses on innovative therapeutic approaches for patients with moderate to severe disease manifestations.
- Moderate to Severe Crohn's Disease Treatment
- Ulcerative Colitis Management
- Novel Therapeutic Interventions
Their work encompasses the evaluation of targeted biological therapies and emerging treatment modalities for IBD patients.
Advanced Therapeutic Development
The investigator's research portfolio includes studies of various monoclonal antibodies and novel therapeutic compounds for inflammatory bowel conditions. Their work examines both induction and maintenance therapy approaches.
- Biological Therapy Assessment
- Treatment Response Evaluation
- Long-term Disease Management
Key areas of focus include endoscopic improvement and clinical remission in inflammatory bowel conditions.
Clinical Outcomes Research
Their research emphasizes the assessment of therapeutic efficacy and clinical responses in gastrointestinal disorders. The investigator evaluates various clinical parameters including endoscopic improvement and symptomatic remission.
- Disease Activity Monitoring
- Therapeutic Response Assessment
- Safety Profile Evaluation
The work includes comprehensive evaluation of treatment outcomes in inflammatory bowel conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.